1. Home
  2. VTMX vs SRPT Comparison

VTMX vs SRPT Comparison

Compare VTMX & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

VTMX

Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

HOLD

Current Price

$34.39

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.12

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTMX
SRPT
Founded
1998
1980
Country
Mexico
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
VTMX
SRPT
Price
$34.39
$17.12
Analyst Decision
Buy
Hold
Analyst Count
2
29
Target Price
$40.00
$25.85
AVG Volume (30 Days)
126.2K
2.7M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
2.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
N/A
$2,198,237,000.00
Revenue This Year
$12.22
N/A
Revenue Next Year
$11.52
N/A
P/E Ratio
$47.91
$5.78
Revenue Growth
N/A
15.58
52 Week Low
$24.99
$10.42
52 Week High
$37.41
$43.92

Technical Indicators

Market Signals
Indicator
VTMX
SRPT
Relative Strength Index (RSI) 45.42 33.75
Support Level $33.84 $16.09
Resistance Level $36.96 $19.32
Average True Range (ATR) 1.19 1.14
MACD -0.20 -0.49
Stochastic Oscillator 50.96 7.59

Price Performance

Historical Comparison
VTMX
SRPT

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: